GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » Price-to-Owner-Earnings

Vitrolife AB (FRA:VTFN) Price-to-Owner-Earnings : 78.89 (As of May. 10, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Price-to-Owner-Earnings?

As of today (2025-05-10), Vitrolife AB's share price is €14.20. Vitrolife AB's Owner Earnings per Share (TTM) ended in Mar. 2025 was €0.18. It's Price-to-Owner-Earnings for today is 78.89.


The historical rank and industry rank for Vitrolife AB's Price-to-Owner-Earnings or its related term are showing as below:

FRA:VTFN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 26.06   Med: 106.89   Max: 385.51
Current: 76.96

During the past 13 years, the highest Price-to-Owner-Earnings of Vitrolife AB was 385.51. The lowest was 26.06. And the median was 106.89.


FRA:VTFN's Price-to-Owner-Earnings is ranked worse than
79.66% of 290 companies
in the Medical Devices & Instruments industry
Industry Median: 29.005 vs FRA:VTFN: 76.96

As of today (2025-05-10), Vitrolife AB's share price is €14.20. Vitrolife AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €0.33. Therefore, Vitrolife AB's PE Ratio (TTM) for today is 43.56.

As of today (2025-05-10), Vitrolife AB's share price is €14.20. Vitrolife AB's EPS without NRI for the trailing twelve months (TTM) ended in was €0.33. Therefore, Vitrolife AB's PE Ratio without NRI for today is 43.56.

During the past 13 years, Vitrolife AB's highest PE Ratio without NRI was 188.55. The lowest was 24.44. And the median was 56.77.


Vitrolife AB Price-to-Owner-Earnings Historical Data

The historical data trend for Vitrolife AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Price-to-Owner-Earnings Chart

Vitrolife AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.00 251.67 154.73 - 78.71

Vitrolife AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 78.71 81.56

Competitive Comparison of Vitrolife AB's Price-to-Owner-Earnings

For the Medical Devices subindustry, Vitrolife AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Price-to-Owner-Earnings falls into.


;
;

Vitrolife AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Vitrolife AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=14.20/0.18
=78.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vitrolife AB  (FRA:VTFN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Vitrolife AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Vitrolife AB Headlines

No Headlines